Report - SYMPOSIUM 37 - TREATING AD: ALTERNATIVES TO … · 4/3/2020  · A single center, open-label, 1-arm, 24-week study to evaluate the efficacy, safety and tolerability of vafidemstat

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form